Page 139 - Read Online

Page 22 of 23 Gutierrez et al. Microbiome Res Rep 2023;2:36 https://dx.doi.org/10.20517/mrr.2023.37

associated with increased inflammation. Inflamm Bowel Dis 2011;17:2299-307. DOI
161. Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2014;20:1165-
79. DOI PubMed PMC
162. Johansson ME, Gustafsson JK, Holmén-Larsson J, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both
murine colitis models and patients with ulcerative colitis. Gut 2014;63:281-91. DOI PubMed PMC
163. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008;454:455-62. DOI PubMed
PMC
164. Shkoda A, Ruiz PA, Daniel H, et al. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on
chronic inflammation. Gastroenterology 2007;132:190-207. DOI
165. Eri RD, Adams RJ, Tran TV, et al. An intestinal epithelial defect conferring ER stress results in inflammation involving both innate
and adaptive immunity. Mucosal Immunol 2011;4:354-64. DOI PubMed PMC
166. Cui QY, Tian XY, Liang X, et al. Bifidobacterium bifidum relieved DSS-induced colitis in mice potentially by activating the aryl
hydrocarbon receptor. Food Funct 2022;13:5115-23. DOI
167. Wang H, Fan C, Zhao Z, Zhai Z, Hao Y. Anti-inflammatory effect of Bifidobacterium animalis subsp. lactis A6 on DSS-induced
colitis in mice. J Appl Microbiol 2022;133:2063-73. DOI
168. Lee SY, Lee BH, Park JH, Park MS, Ji GE, Sung MK. Bifidobacterium bifidum BGN4 paraprobiotic supplementation alleviates
experimental colitis by maintaining gut barrier and suppressing nuclear factor kappa B activation signaling molecules. J Med Food
2022;25:146-57. DOI PubMed
169. Yan S, Yang B, Ross RP, et al. Bifidobacterium longum subsp. longum YS108R fermented milk alleviates DSS induced colitis via
anti-inflammation, mucosal barrier maintenance and gut microbiota modulation. J Funct Foods 2020;73:104153. DOI
170. Park IS, Kim JH, Yu J, et al. Bifidobacterium breve CBT BR3 is effective at relieving intestinal inflammation by augmenting goblet
cell regeneration. J Gastroenterol Hepatol 2023;38:1346-54. DOI
171. Singh S, Bhatia R, Khare P, et al. Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and
associated gut microbial dysbiosis in mice. Sci Rep 2020;10:18597. DOI
172. Chen Y, Jin Y, Stanton C, et al. Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract
barrier maintenance and gut microbiota modulation. Eur J Nutr 2021;60:369-87. DOI
173. Chen Y, Zhang L, Hong G, et al. Probiotic mixtures with aerobic constituent promoted the recovery of multi-barriers in DSS-induced
chronic colitis. Life Sci 2020;240:117089. DOI
174. Niu MM, Guo HX, Cai JW, Meng XC. Bifidobacterium breve alleviates DSS-induced colitis in mice by maintaining the mucosal and
epithelial barriers and modulating gut microbes. Nutrients 2022;14:3671. DOI
175. Zhou L, Liu D, Xie Y, Yao X, Li Y. Bifidobacterium infantis induces protective colonic PD-L1 and foxp3 regulatory T cells in an
acute murine experimental model of inflammatory bowel disease. Gut Liver 2019;13:430-9. DOI
176. Zuo L, Yuan KT, Yu L, Meng QH, Chung PC, Yang DH. Bifidobacterium infantis attenuates colitis by regulating T cell subset
responses. World J Gastroenterol 2014;20:18316-29. DOI
177. Chen M, Liu C, Dai M, Wang Q, Li C, Hung W. Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in
zebrafish models. PLoS One 2022;17:e0262942. DOI
178. Roselli M, Finamore A, Nuccitelli S, et al. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains
is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis
2009;15:1526-36. DOI PubMed
179. Martín R, Laval L, Chain F, et al. Bifidobacterium animalis ssp. lactis CNCM-I2494 restores gut barrier permeability in chronically
low-grade inflamed mice. Front Microbiol 2016;7:608. DOI PubMed PMC
180. Yue Y, Wang Y, Xie Q, et al. Bifidobacterium bifidum E3 combined with Bifidobacterium longum subsp. infantis E4 improves LPS-
induced intestinal injury by inhibiting the TLR4/NF-κB and MAPK signaling pathways in vivo. J Agric Food Chem 2023;71:8915-
30. DOI PubMed
181. Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing
enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009;297:G940-9. DOI PubMed PMC
182. Lueschow SR, Boly TJ, Frese SA, et al. Bifidobacterium longum subspecies infantis strain EVC001 decreases neonatal murine
necrotizing enterocolitis. Nutrients 2022;14:495. DOI PubMed PMC
183. Bergmann KR, Liu SX, Tian R, et al. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in
mouse necrotizing enterocolitis. Am J Pathol 2013;182:1595-606. DOI
184. Braga TD, da Silva GAP, de Lira PIC, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral
supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial.
Am J Clin Nutr 2011;93:81-6. DOI PubMed
185. Kawahara T, Makizaki Y, Oikawa Y, et al. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis
through regulation of intestinal homeostasis by inducing mucosal protective factors. PLoS One 2017;12:e0173979. DOI
186. Weng M, Ganguli K, Zhu W, Shi HN, Walker WA. Conditioned medium from Bifidobacteria infantis protects against Cronobacter
sakazakii-induced intestinal inflammation in newborn mice. Am J Physiol Gastrointest Liver Physiol 2014;306:G779-87. DOI
187. Engevik KA, Matthis AL, Montrose MH, Aihara E. Organoids as a model to study infectious disease. In: Medina C, López-baena FJ,
editors. Host-Pathogen Interactions. New York: Springer; 2018. p. 71-81. DOI